We are live on ! Find out more
STXS icon

Stereotaxis

51 hedge funds and large institutions have $96.3M invested in Stereotaxis in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 7

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

6% more funds holding

Funds holding: 4851 (+3)

1.8% more ownership

Funds ownership: 44.37%46.16% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

39% less capital invested

Capital invested by funds: $157M → $96.3M (-$60.6M)

Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
1.12%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
13
Increased
20
Reduced
7
Closed
8
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
+$6K
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
1
DAFNA Capital Management
California
$41.3M
APCM
2
Arbiter Partners Capital Management
New York
$14.1M
OM
3
Opaleye Management
Massachusetts
$11.7M -$1.04M -251,000 -6%
RG
4
Redmile Group
California
$9.37M -$273K -65,981 -2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.85M +$2.07M +500,300 +45%
PVI
6
Pura Vida Investments
New York
$3.11M +$3.24M +785,178 +322%
PHP
7
Parkman Healthcare Partners
Connecticut
$1.97M +$504K +121,975 +23%
Millennium Management
8
Millennium Management
New York
$1.48M +$965K +233,438 +92%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$1.05M +$780K +188,811 +120%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$737K +$136K +32,925 +16%
EIM
11
Essex Investment Management
Massachusetts
$735K -$54.4K -13,160 -5%
ECM
12
ExodusPoint Capital Management
New York
$718K +$649K +157,101 +195%
EI
13
EAM Investors
California
$610K +$33.3K +8,063 +4%
Goldman Sachs
14
Goldman Sachs
New York
$477K +$581K +140,733 +812%
UBS Group
15
UBS Group
Switzerland
$354K +$480K +116,087 +10,033%
MCM
16
Marathon Capital Management
Maryland
$330K +$452K +109,500 New
Arrowstreet Capital
17
Arrowstreet Capital
Massachusetts
$328K +$449K +108,629 New
Two Sigma Advisers
18
Two Sigma Advisers
New York
$262K +$359K +86,900 New
BlackRock
19
BlackRock
New York
$228K +$9.42K +2,280 +3%
SV
20
Sturgeon Ventures
United Kingdom
$227K +$311K +75,213 New
LIM
21
Lagoda Investment Management
New York
$223K +$45.5K +11,000 +17%
Northern Trust
22
Northern Trust
Illinois
$212K +$56K +13,552 +24%
Squarepoint
23
Squarepoint
New York
$210K -$74.8K -18,093 -21%
Wells Fargo
24
Wells Fargo
California
$180K +$139K +33,533 +130%
Morgan Stanley
25
Morgan Stanley
New York
$156K +$213K +51,439 +25,092%

STXS Hedge Fund Activity: Q1 2020 in Review

51 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q1 2020, worth a combined $96.3M — down 39% from $157M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new STXS positions and 8 closed out — a net gain of 5 holders — while 20 added to existing stakes and 7 trimmed.

The largest buyer was Pura Vida Investments, adding an estimated $3.24M. The largest seller was Opaleye Management, cutting an estimated $1.04M.

  • 51 institutional investors held Stereotaxis (STXS) as of Q1 2020, up from 48 in Q4 2019.
  • Funds reported $96.3M of Stereotaxis stock for Q1 2020, down 39% quarter-over-quarter.
  • 13 funds opened new Stereotaxis positions in Q1 2020 and 8 closed out, a net change of +5 holders.
  • The largest Stereotaxis buyer in Q1 2020 was Pura Vida Investments, an estimated $3.24M added.
  • The largest Stereotaxis seller in Q1 2020 was Opaleye Management, an estimated $1.04M sold.

Based on aggregated 13F filings for Q1 2020.